A. Bielik

发表

A high throughput luminescent assay for glycogen synthase kinase-3beta inhibitors.

L. Molnár, G. Keserü, A. Baki, 2007, Assay and drug development technologies.

Carbamoyloximes as novel non-competitive mGlu5 receptor antagonists.

J. Galambos, B. Kiss, L. Molnár, 2010, Bioorganic & medicinal chemistry letters.

Novel solid-phase synthesis of 2,6-disubstituted 4(3H)-quinazolinones for combinatorial library generation

G. Szendrei, I. Greiner, A. Bielik, 2002 .

Hit-to-lead optimization of disubstituted oxadiazoles and tetrazoles as mGluR5 NAMs.

B. Kiss, L. Molnár, G. Keserű, 2010, Bioorganic & medicinal chemistry letters.

Indole-2-carboxamides as novel NR2B selective NMDA receptor antagonists.

B. Ágai, A. Gere, C. Kiss, 2003, Bioorganic & medicinal chemistry letters.

Solid-phase synthesis of 6-hydroxy-2,4-diaminoquinazolines

G. Keserű, G. Szendrei, I. Greiner, 2005 .

Discovery and Preclinical Characterization of 3-((4-(4-Chlorophenyl)-7-fluoroquinoline-3-yl)sulfonyl)benzonitrile, a Novel Non-acetylenic Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric Modulator for Psychiatric Indications.

J. Galambos, G. Balogh, G. Keserű, 2017, Journal of medicinal chemistry.

Solid-phase synthesis of an N-(phenylalkyl)cinnamide library via Horner-Wadsworth-Emmons reaction.

G. Keserű, G. Szendrei, I. Greiner, 2004, Bioorganic & medicinal chemistry letters.

Discovery of 4-amino-3-arylsulfoquinolines, a novel non-acetylenic chemotype of metabotropic glutamate 5 (mGlu5) receptor negative allosteric modulators.

J. Galambos, B. Kiss, G. Keserű, 2017, European journal of medicinal chemistry.